Amyris | Biotechnology Company Amyris honored by 2021 World Changing Ideas Awards Our shark-saving squalene for use in coronavirus and other vaccine adjuvants received honorable mention Fast Company
About | Amyris Biotechnology Company At Amyris, we aim big and broad, creating prosperity for people, the planet, and business So that we can continue to deliver on the promise of synthetic biology and make a lasting impact
Science Revolutionary Technology Platform - Amyris Amyris is set to make 2021 a breakout year With growing brands, increased demand for clean products and a strong pipeline, our future is as bright as ever chemweek
Pure Ingredients Clean Chemistry - Amyris Amyris’ pharmaceutical grade, sugarcane-derived squalene can sustainably scale to respond to global health crises and sudden spikes in demand learn more A fermentation-derived, natural molecule that is bioidentical to Reb M, the sweetest and most rare steviol glycoside in the stevia plant
Sustainability With No Compromise - Amyris Amyris is a proud sponsor of the 12th SIF in November 2022 and will join state and multilaterals, environment ministers, business leaders, investors, NGOs, and more to discuss the path forward to a more sustainable future Amyris continues to be a champion of the UN Sustainable Development Goals (SDG) and is a proud member of the UN Global Compact
Press Release - MAY 29 2025 - Amyris Amyris, Inc , a vertically integrated synthetic biology company and leading innovator in the field of industrial biotechnology, and Ingredion Incorporated (NYSE: INGR), a leading global provider of ingredient solutions to the food manufacturing industry, today announced an agreement to wind down their RealSweet joint venture
Newsroom | Amyris Biotechnology Company amyris awarded agreement from biomap-consortium to develop critical medicines to support resilient domestic supply goals Amyris aims to develop up to three small molecule drugs over the next two years – all of which are on the FDA drug shortage list
Welcome to Our New Website. - Amyris From our scientists to our global brand educators to our operations team and everyone in between, what connects us all at Amyris is our relentless passion to leave a positive mark on this world We are purpose-driven in everything we do, and we don’t stop at good enough
Press Release - MAY 29, 2025 - Amyris Amyris, Inc , a vertically integrated synthetic biology company and leading innovator in the field of industrial biotechnology, today announced that it has acquired Ingredion’s 31% stake in the RealSweet Joint Venture to take full ownership of the industrial precision fermentation plant in Barra Bonita, Brazil
Press Release - NOV 19, 2024 - Amyris Amyris, Inc , a vertically integrated synthetic biology company and leading innovator in the field of industrial biotechnology, today announced that, following the completion of a strategic review of its global R D operations and business model, the company has made the decision to consolidate its R D footprint in the U S and Brazil and cease